Senator warns US could plot strike against Syria under pretext of alleged chemical attackRussian Politics & Diplomacy June 27, 16:16
Russian, Ukrainian companies' websites under massive cyber attackWorld June 27, 16:14
Seoul mayor presents his 'e-government' urban administration system to TASSWorld June 27, 15:35
Envoy says military dialogue may help ensure safety over Baltic SeaRussian Politics & Diplomacy June 27, 15:13
Rosneft reports massive cyberattack on its serversBusiness & Economy June 27, 15:08
Russia’s advanced drone helicopters to be displayed at defense showMilitary & Defense June 27, 14:56
Russia fully complies with terms of oil production cut deal — Energy MinistryBusiness & Economy June 27, 14:29
Kremlin has no information about pending chemical attacks in SyriaRussian Politics & Diplomacy June 27, 14:26
Russian hi-tech firm to feature submarine Internet technology at St. Petersburg naval showMilitary & Defense June 27, 13:58
GENEVA, October 3. /TASS/. The Court of Arbitration for Sport (CAS) is set to announce a decision on the appeal of Russian tennis star Maria Sharapova, submitted in summer against her two-year ban, on Tuesday, October 4, the court said in its statement on Monday.
"Decision in the case of Maria Sharapova v. International Tennis Federation to be released at 3.00 pm (Swiss time) on 4 October 2016," the statement said.
On June 9, Sharapova filed an appeal with the CAS in Switzerland’s Lausanne against her two-year suspension, which was imposed on June 8 by the International Tennis Federation’s (ITF) Tribunal over anti-doping violations.
Due to the imposed ban world’s former No. 1 Sharapova had to miss the 2016 Summer Olympic Games, held in August in Brazil’s Rio de Janeiro.
In early March, Sharapova announced that her doping tests revealed the presence of performance enhancing drug meldonium in the body system. Following the announcement, former World’s No. 1 was provisionally suspended from all tennis-related activities.
The drug meldonium (mildronate) was included in the list of preparations banned by WADA from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
WADA announced on April 13 that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.